Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Atropine sulfate
Drug ID BADD_D00190
Description An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.
Indications and Usage For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides.
Marketing Status Prescription; Discontinued
ATC Code A03BA01; S01FA01
DrugBank ID DB00572
KEGG ID D02069
MeSH ID D001285
PubChem ID 60196398
TTD Drug ID D0RG3O
NDC Product Code 51662-1509; 51662-1527; 0404-9823; 0404-9822; 13985-606; 52584-630; 0409-1630; 51552-1391; 0641-6006; 50268-118; 71872-7100; 70518-3120; 38779-2267; 71872-7037; 52584-002; 76329-3340; 51662-1339; 50090-4524; 51662-1311; 0404-9820; 52584-401; 63323-580; 50090-5924; 16729-512; 0409-4910; 50090-3138; 0409-4911; 16729-483; 52584-910; 0404-9821; 71872-7255; 0404-9824; 52584-029; 13371-387; 63827-1014; 71872-7002; 69205-736; 71872-7001; 71872-7245; 0517-1010; 0641-6251; 0404-9819; 16729-484; 76329-3339; 0409-9630; 16729-526; 43235-0004; 51662-1378; 51662-1289; 50090-3104; 52584-044; 51662-1207; 12714-031; 42385-736; 17478-215; 71684-0303; 70121-1705; 0517-0401; 62991-2842; 60505-6226; 62068-306; 52221-107; 55742-124; 76003-0157; 51662-1208; 71872-7246; 69205-031; 16729-525; 71872-7017; 0065-0303; 71872-7252; 24208-825; 51927-0156
Synonyms Atropine | Atropinol | Atropine Sulfate | Sulfate, Atropine | Atropine Sulfate Anhydrous | Anhydrous, Atropine Sulfate | Sulfate Anhydrous, Atropine | AtroPen | Atropin Augen？l | Augen？l, Atropin
Chemical Information
Molecular Formula C34H48N2O10S
CAS Registry Number 55-48-1
SMILES CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.OS(= O)(=O)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash scarlatiniform23.03.13.006--Not Available
Red blood cell count increased13.01.05.008--Not Available
Respiration abnormal22.02.08.011--Not Available
Respiratory failure14.01.04.003; 22.02.06.002--
Restlessness17.02.05.021; 19.11.02.002--
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.001--
Sinus tachycardia02.03.03.010--
Skin discolouration23.03.03.005--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin warm23.03.03.014--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Strabismus06.05.02.004; 17.17.01.009--Not Available
Stridor22.04.02.003--
Stupor17.02.04.007; 19.02.05.004--Not Available
Supraventricular extrasystoles02.03.03.011--Not Available
Supraventricular tachycardia02.03.03.012--
Syncope02.01.02.008; 17.02.04.008; 24.06.02.012--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.014--Not Available
Thirst08.01.09.021; 14.03.02.007--Not Available
Tremor17.01.06.002--
Urinary hesitation20.02.02.009--Not Available
Urinary retention20.02.02.011--
Ventricular arrhythmia02.03.04.006--
Ventricular extrasystoles02.03.04.007--Not Available
Ventricular fibrillation02.03.04.008--
Ventricular flutter02.03.04.009--Not Available
Ventricular tachycardia02.03.04.010--
Vertigo04.04.01.003; 17.02.12.002--
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages